2019
DOI: 10.1111/liv.14232
|View full text |Cite
|
Sign up to set email alerts
|

Hepatitis C virus elimination in Indonesia: Epidemiological, cost and cost‐effectiveness modelling to advance advocacy and strategic planning

Abstract: Backgrounds & Aims:In Indonesia 1.9 million people are chronically infected with hepatitis C virus (HCV), but a national strategic plan for elimination has not yet been developed, despite the availability of low-cost treatments which could save many lives. We used epidemiological and cost modelling to estimate targets and resource requirements of a national elimination program and explore the potential impact and cost-effectiveness. Methods: To model the HCV epidemic, we used a dynamic model, parameterised wit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
20
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
5
2

Relationship

2
5

Authors

Journals

citations
Cited by 12 publications
(21 citation statements)
references
References 27 publications
0
20
0
Order By: Relevance
“…Based on previous report from Indonesia, an average cost before starting HCV therapy was USD 191, including USD 74 for TE examination. [2] This high cost could delay treatment initiation for many patients though government provide the drugs. As the majority of HCV infection in Indonesia were driven by unsafe opiate injection around year 2000, we could predict that many untreated HCV-HIV co-infected patients have already in their cirrhosis stage.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…Based on previous report from Indonesia, an average cost before starting HCV therapy was USD 191, including USD 74 for TE examination. [2] This high cost could delay treatment initiation for many patients though government provide the drugs. As the majority of HCV infection in Indonesia were driven by unsafe opiate injection around year 2000, we could predict that many untreated HCV-HIV co-infected patients have already in their cirrhosis stage.…”
Section: Discussionmentioning
confidence: 99%
“…[19,20] Since the Indonesian government planned to expand free DAA program for HCV, the result our study could be implemented in many places, as WHO also recommends to use APRI and FIB-4 in resourceconstraint countries. [2,14] This study has several limitations. First, the number of end-stage liver diseases were small.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…[1] In Indonesia, HCV infection prevalence is estimated at 1%, of which 90% comes from intravenous drug user. [2] World Health Organization (WHO) recently released targets for HCV elimination by 2030, targeting 80% HCV-infected patients being treated. [1] A large gap between HCV-diagnosed patients and HCV-treated patients still exist to achieve this global target since only around 10% of HCVinfected patients in South East Asia have been treated.…”
Section: Introductionmentioning
confidence: 99%